Prothena Reports Non-Competitive Brain Swelling Rates In Early Alzheimer's Study
Prothena Corporation plc (NASDAQ:PRTA) shared results on Wednesday from the Phase 1 ASCENT clinical program in participants with early symptomatic Alzheimer’s disease (AD).
Benzinga ·